These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 36012417)

  • 21. Biomarkers of Bladder Cancer: Cell-Free DNA, Epigenetic Modifications and Non-Coding RNAs.
    Harsanyi S; Novakova ZV; Bevizova K; Danisovic L; Ziaran S
    Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361996
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnostic Value of Combination of MicroRNA-192 in Urinary Sediment and B-Ultrasound for Bladder Cancer.
    Jiang F; Li C; Han J; Wang L
    Technol Cancer Res Treat; 2020; 19():1533033819894573. PubMed ID: 32106776
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comet-FISH analysis of urothelial cells. A screening opportunity for bladder cancer?
    La Maestra S; Benvenuti M; D'Agostini F; Micale RT
    Expert Rev Mol Diagn; 2023; 23(8):653-663. PubMed ID: 37334662
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Liquid biopsy to indvidualise therapy in advanced bladder cancer].
    Junker K
    Aktuelle Urol; 2022 Apr; 53(2):180-187. PubMed ID: 34875700
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Highly sensitive and specific novel biomarkers for the diagnosis of transitional bladder carcinoma.
    Kumar P; Nandi S; Tan TZ; Ler SG; Chia KS; Lim WY; Bütow Z; Vordos D; De la Taille A; Al-Haddawi M; Raida M; Beyer B; Ricci E; Colombel M; Chong TW; Chiong E; Soo R; Park MK; Ha HK; Gunaratne J; Thiery JP
    Oncotarget; 2015 May; 6(15):13539-49. PubMed ID: 25915536
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of miR-182/miR-100 Ratio for Diagnosis and Survival Prediction in Bladder Cancer.
    Chen Z; Wu L; Lin Q; Shi J; Lin X; Shi L
    Arch Iran Med; 2016 Sep; 19(9):645-51. PubMed ID: 27631180
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Methylation of a panel of microRNA genes is a novel biomarker for detection of bladder cancer.
    Shimizu T; Suzuki H; Nojima M; Kitamura H; Yamamoto E; Maruyama R; Ashida M; Hatahira T; Kai M; Masumori N; Tokino T; Imai K; Tsukamoto T; Toyota M
    Eur Urol; 2013 Jun; 63(6):1091-100. PubMed ID: 23200812
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNAs as Biomarkers for the Diagnostics of Bladder Cancer: a Meta-Analysis.
    Chen L; Cui Z; Liu Y; Bai Y; Lan F
    Clin Lab; 2015; 61(8):1101-8. PubMed ID: 26427157
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Liquid biopsy in the clinical management of bladder cancer: current status and future developments.
    Kouba E; Lopez-Beltran A; Montironi R; Massari F; Huang K; Santoni M; Chovanec M; Cheng M; Scarpelli M; Zhang J; Cimadamore A; Cheng L
    Expert Rev Mol Diagn; 2020 Feb; 20(2):255-264. PubMed ID: 31608720
    [No Abstract]   [Full Text] [Related]  

  • 30. Diagnostic and prognostic role of urinary collagens in primary human bladder cancer.
    Miyake M; Morizawa Y; Hori S; Tatsumi Y; Onishi S; Owari T; Iida K; Onishi K; Gotoh D; Nakai Y; Anai S; Chihara Y; Torimoto K; Aoki K; Tanaka N; Shimada K; Konishi N; Fujimoto K
    Cancer Sci; 2017 Nov; 108(11):2221-2228. PubMed ID: 28837258
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification and validation of the methylated TWIST1 and NID2 genes through real-time methylation-specific polymerase chain reaction assays for the noninvasive detection of primary bladder cancer in urine samples.
    Renard I; Joniau S; van Cleynenbreugel B; Collette C; Naômé C; Vlassenbroeck I; Nicolas H; de Leval J; Straub J; Van Criekinge W; Hamida W; Hellel M; Thomas A; de Leval L; Bierau K; Waltregny D
    Eur Urol; 2010 Jul; 58(1):96-104. PubMed ID: 19674832
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A microRNA biomarker panel for the non-invasive detection of bladder cancer.
    Urquidi V; Netherton M; Gomes-Giacoia E; Serie DJ; Eckel-Passow J; Rosser CJ; Goodison S
    Oncotarget; 2016 Dec; 7(52):86290-86299. PubMed ID: 27863434
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genomic profile of urine has high diagnostic sensitivity compared to cytology in non-invasive urothelial bladder cancer.
    Hirotsu Y; Yokoyama H; Amemiya K; Hagimoto T; Daimon H; Hosaka K; Oyama T; Mochizuki H; Omata M
    Cancer Sci; 2019 Oct; 110(10):3235-3243. PubMed ID: 31368627
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Independent verification of circulating miRNA as diagnostic biomarkers for urothelial carcinoma.
    Urabe F; Matsuzaki J; Takeshita F; Kishida T; Ochiya T; Hirai K
    Cancer Sci; 2022 Oct; 113(10):3510-3517. PubMed ID: 35848873
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Liquid biopsy of gastric cancer patients: circulating tumor cells and cell-free nucleic acids.
    Tsujiura M; Ichikawa D; Konishi H; Komatsu S; Shiozaki A; Otsuji E
    World J Gastroenterol; 2014 Mar; 20(12):3265-86. PubMed ID: 24696609
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative evaluation of the nuclear matrix protein, fibronectin, urinary bladder cancer antigen and voided urine cytology in the detection of bladder tumors.
    Eissa S; Swellam M; Sadek M; Mourad MS; El Ahmady O; Khalifa A
    J Urol; 2002 Aug; 168(2):465-9. PubMed ID: 12131289
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Urinary Cell-Free DNA IQGAP3/BMP4 Ratio as a Prognostic Marker for Non-Muscle-Invasive Bladder Cancer.
    Xu Y; Kim YH; Jeong P; Piao XM; Byun YJ; Seo SP; Kang HW; Kim WT; Lee JY; Ryu DH; Choi JW; Kim IY; Moon SK; Choi YH; Yun SJ; Kim WJ
    Clin Genitourin Cancer; 2019 Jun; 17(3):e704-e711. PubMed ID: 31088707
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Carbonic anhydrase IX as a diagnostic urinary marker for urothelial bladder cancer.
    de Martino M; Lucca I; Mbeutcha A; Wiener HG; Haitel A; Susani M; Shariat SF; Klatte T
    Eur Urol; 2015 Oct; 68(4):552-4. PubMed ID: 26138037
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HOXA9, PCDH17, POU4F2, and ONECUT2 as a Urinary Biomarker Combination for the Detection of Bladder Cancer in Chinese Patients with Hematuria.
    Wu Y; Jiang G; Zhang N; Liu S; Lin X; Perschon C; Zheng SL; Ding Q; Wang X; Na R; Sun J; Xu J
    Eur Urol Focus; 2020 Mar; 6(2):284-291. PubMed ID: 30309818
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DNA Hypermethylation af a Panel Of Genes as an Urinary Biomarker For Bladder Cancer Diagnosis.
    Georgopoulos P; Papaioannou M; Markopoulou S; Fragou A; Kouvatseas G; Apostolidis A
    Urol J; 2021 Nov; 19(3):214-220. PubMed ID: 34806159
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.